Keyphrases
Myositis-specific Antibodies
52%
Systemic Sclerosis
48%
Narrative Review
48%
Induced Liver Injury
48%
Checkpoint Inhibitors
48%
Corticosteroids
48%
Liver Biopsy
48%
Euroline
48%
Clinical Practice
48%
Immunoblot
48%
Differential Diagnosis
48%
Commercial Kits
48%
Idiopathic Inflammatory Myopathies
48%
Antibody Detection
48%
Composite Score
48%
Idiopathic Inflammatory Myositis
41%
Autoantibodies
32%
Necroinflammation
24%
Particle-based
20%
TIF1
20%
Melanoma Differentiation-associated Gene 5 (MDA5)
20%
Multi-analyte
20%
Dermatomyositis
14%
HMG-CoA Reductase
13%
PL-12
13%
Ribonucleoprotein
12%
Malignancy
12%
Anti-PD-1
12%
Transaminases
12%
Method Validation
9%
Immunoblot Assay
9%
Stratification Tools
6%
Odds Ratio
6%
Mi-2
6%
Jo-1
6%
Diagnostic Performance
6%
Diagnostic Research
6%
Overall Sensitivity
6%
Diagnostic Tool
6%
Individual Control
6%
Antisynthetase Syndrome
6%
Clinical Performance
6%
Research Use
6%
NXP2
6%
Group 12
6%
Sensitivity Specificity
6%
Anti-RNA Polymerase III Antibodies
6%
Key Biomarkers
6%
Gastrointestinal Dysmotility
6%
Pulmonary Fibrosis
6%
Biochemistry, Genetics and Molecular Biology
Autoantibodies
48%
Transaminase
48%
Antibodies
48%
Ribonucleoprotein
32%
CTLA-4
24%
PD-L1
24%
Bilirubin
24%
Prospective Study
24%
Memory B Cell
24%
CD8
24%
Immunophenotyping
24%
HLA-DR
24%
MDA5
20%
DNA Topoisomerase
16%
Topoisomerase
16%
Centromere
16%
RNA Polymerase III
16%
Alternative Splicing
16%
Immunology and Microbiology
Immunology
100%
Myositis
54%
Antibodies
54%
Systemic Scleroderma
48%
Western Blot
48%
Autoantibodies
42%
Dermatomyositis
24%
Prevalence
12%
MDA5
11%
RNA Polymerase
6%
Centromere
6%
Alternative RNA Splicing
6%
Ribonucleoprotein Antibody
6%
Cancer Screening
6%
ELISA
6%
Immunoprecipitation
6%
Connective Tissue
6%
